Motor Neuron Disease Clinical Trial
Official title:
Technical Evaluation and Usability Analysis of a Novel Ear-worn Assistive Device
The goal of this study is to test the Earswitch device in both participants with and without assistive technology (AT) needs. The main aim is to determine how robust the Earswitch is in detecting voluntary eardrum movements (known as ear rumbling) and see how well the Earswitch fits with other assistive technology. To do this, participants will be asked to wear the Earswitch device and voluntarily contract their TT to complete a series of tasks shown on screen and/or explained audibly. Participants will be asked to complete questionnaires to understand their opinions about the effectiveness, usability, and comfort of both their current device (if applicable) and the Earswitch. This feedback will be invaluable in developing the Earswitch.
The overall aim of this study is to evaluate the robustness of the EarSwitch technology (hardware and software) in detecting voluntary eardrum movements in people with assistive needs. This is a key step to ensure a robust design informed by patients' needs. A secondary aim is to gather information from assistive device users about how well they can perform voluntary eardrum movements, as this knowledge will be used to inform what types of interfaces are appropriate for the Earswitch. Healthy participants will also be recruited as a separate cohort, to maximise the amount of data collected which can be used to validate and inform future designs. The methodology will be the same across both cohorts with the same equipment (Earswitch, second screen, and laptop) being used, however the healthy participants will not be able to answer all questions in PART 1. Healthy participants will be invited into a University lab to undertake the study, whereas participants with assistive technology needs will be given the option of a home visit. As the same equipment will be used, only the environment (i.e., home vs lab) will change which is not anticipate to affect the study data. At the start of the study a signal will be agreed with the participant (and carer when required) so that the participant can inform their carer and/or the experimenter if they wish to stop the study for any reason. The proposed study will take place in a single session and includes four main parts: PART 1 - Co-design Questionnaires. The specific aims for this part are to collect data on what assistive technologies people use and gain feedback on current switch technologies to better understand how the Earswitch can be integrated in conjunction with other switch technology. The participants will be asked questions to understand the type of assistive technology (hardware and software) they currently use. This will include their opinions about the effectiveness, usability, and comfort of their current device, measured using the previously validated QUEST2 questionnaire. This process should not take more than 15 minutes, and will be carried out by the researcher, with the support of a carer where necessary. PART 2 - Earswitch insertion. Following this, the participant, with the help of the experimenter or the carer, will select an earbud size which will be inserted into the participant's ear. The participant will then be asked if it is comfortable or whether they would like to try a different size according to the comfort or fit of the earbud. Once the participant is happy with the size of the earbud, the experiment or the carer will install the Earswitch device, which involves putting a small camera into the participant's ear canal and positioning it so that it can see their eardrum. During this procedure, the participant will be asked to let the experimenter or carer know if it is uncomfortable or if they wish to stop. This should be no different to putting a regular ear bud into the participant's ear. Once this is complete, the participant will be asked some questions about the comfort of the device, and how easy they felt the installation process was. Once the Earswitch has been inserted, the experimenter will take a measurement of how far the otoscope is inserted into the ear, by using a ruler to measure the extruding element (with which the depth of the otoscope can be calculated). In addition, the experimenter will take a close-up picture of the Earswitch sitting in the concha to provide visual evidence of the fit (i.e., how the silicone earbud sits in the concha) and to identify any potential pressure points (e.g., on the tragus) that may help explain the device comfort. Part two is scheduled to last 10 minutes. PART 3 - Ear rumbling test. Next, some videos will be recorded by the Earswitch device of the participant's ear drum while they contract the tensor tympani (TT) muscle voluntarily in response to several tasks. The tasks will ask the participant to voluntarily contract the TT muscle in response to different stimuli when requested. These stimuli will be presented to the participant either visually on a screen, audibly through some speakers, or both depending on their sight and hearing. The purpose of this is to see how well the participant can voluntarily contract their TT muscle on demand, and to see how well the Earswitch can recognise this. The tasks will involve the participant contracting their TT muscle voluntarily in response to a presented stimulus, twice in a row, multiple times in a row, and they will be asked to hold the muscle contraction for certain periods of time (1 second, 2 seconds, as long as possible). In addition, the participant's eardrum will be recorded when they perform everyday tasks to make sure that the Earswitch does not accidentally activate when it shouldn't. The everyday tasks will be selected based on the capability of the participant, but will include (at minimum) doing whatever they wish for two minutes, and communicating with their existing communication device fortwo minutes. If possible, the participant will be asked to yawn, move their head, and drink some water. During these tasks the participant will not get any immediate feedback from the system, instead it will be recording the data which will be analysed after they have finished the study. The videos will be recorded using the Earswitch device in the participant's ear, and will therefore only contain anonymous images of their ear drum. This means that no-one will be able to identify the participant from the videos taken as no personally identifiable data will be stored alongside the videos. Finally, the participant will be asked to complete some questionnaires about their experiences with the Earswitch device, including the comfort of the device and how easy it was to use. This part of the study should last about 10minutes.This part of the study should take about 25 minutes. PART 4 - Usability testing (optional). Following this data collection, the participant will be asked if they would like to interact with some interfaces using the Earswitch device. There will be three interfaces which the participant can try which involve text entry using a switch scanning keyboard, a target acquisition task which provides immediate feedback, and a game. The participant can complete these applications in any order they wish, and for as long as they wish. The purpose of this task is to provide an opportunity for the participant to use the Earswitch for real-time interaction using real-world tasks. This will be followed by further questionnaires to understand the participant's perception of interacting with the Earswitch. This part of the study should last about 15-20 minutes. At the end of the study the participant will have the opportunity to provide the research team with their contact details(e.g., an email address or telephone number) in the event that they would like to receive updates about the study results, the development of the Earswitch, or if they would like to participate in future studies involving the Earswitch. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04579666 -
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
|
Phase 2 | |
Completed |
NCT03706391 -
Study of ALS Reversals 4: LifeTime Exposures
|
||
Active, not recruiting |
NCT03067857 -
Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02464748 -
Telehealth in Motor Neurone Disease
|
N/A | |
Completed |
NCT00956488 -
Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis
|
Phase 1/Phase 2 | |
Terminated |
NCT00537446 -
Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis
|
N/A | |
Recruiting |
NCT04944940 -
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
|
||
Recruiting |
NCT03362658 -
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
|
||
Completed |
NCT00714636 -
Cerebrospinal Fluid Repository
|
N/A | |
Completed |
NCT00071435 -
Brain Function in Primary Lateral Sclerosis
|
N/A | |
Completed |
NCT00076687 -
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
|
Phase 2 | |
Completed |
NCT00001220 -
Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders
|
N/A | |
Completed |
NCT03487263 -
Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease
|
Phase 1 | |
Enrolling by invitation |
NCT05725759 -
Rehabilitation in SOD1 ALS Treated With Tofersen
|
||
Active, not recruiting |
NCT03811301 -
[BrainConnexion] - Neurodevice Phase I Trial
|
N/A | |
Completed |
NCT02469896 -
A Trial of Tocilizumab in ALS Subjects
|
Phase 2 | |
Completed |
NCT02011204 -
Study of Electrical Impedance Myography (EIM) in ALS
|
N/A | |
Completed |
NCT01495390 -
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
|
N/A | |
Completed |
NCT02870634 -
Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND
|
Phase 1 | |
Recruiting |
NCT06201650 -
Neurofilament Light Chain in Amyotrophic Lateral Sclerosis
|